Trademark: 86918301
Status Date
Tuesday, August 17, 2021
Filing Date
Wednesday, February 24, 2016
Published for Opposition
Tuesday, August 17, 2021
1 growth factors for medical purposes, in the nature of protein based cell growth media for growing cells for scientific or research use
5 medical and surgical dressings; dressing systems for postoperative care comprising medical dressings and splints; growth factors for medical purposes, in the nature of protein based cell growth media for growing cells for medical use; allograft material, namely, protein stimulating growth factors for medical purposes, in particular, proteins for promoting tissue growth and repair; protein stimulating bone growth factors used for bone void fillers and bone regeneration, namely, bone growth media consisting of biological materials for medical purposes
8 hand tools, namely, hand operated personal assistance devices for grasping and picking up objects
9 downloadable computer software for medical practice management and for the management of patient medical records; downloadable computer software used to track and guide surgical implant placement; electronic pressure map systems consisting of pressure sensors used in shoes, orthotics, shoe insoles, braces, splints or postoperative walker boots for assessing foot loading by measuring and storing foot pressure distribution information for analysis
10 orthopedic bone implants made of artificial materials; bone prostheses; joint prostheses; none of the foregoing goods including hip implants or hip prostheses; orthopedic fixation devices, namely, screws, plates; splints; orthopedic braces; boots for medical purposes; personal mobility aids, namely, rollators, walkers, crutches, wheelchairs; medical apparatus, namely, whole-body and partial-body cryotherapy chambers for removing heat from targeted areas of human tissue as a local anesthesia, to increase mobility of body parts, and to reduce inflammation; anesthetic delivery apparatus, namely, syringes, intravenous lines in the nature of intravenous catheters and masks for inhaling anaesthesia; perioperative pain medication delivery apparatus, namely, syringes, intravenous lines in the nature of intravenous catheters, masks for inhaling pharmaceutical preparations, catheters and patient-controlled analgesic (PCA) infusion pumps; padding for orthopedic casts; electrotherapy devices for providing transcutaneous electrical nerve stimulation; surgical instruments; surgical implant placement guides; protein stimulating bone growth factors used for bone void fillers and bone regeneration, namely, artificial bone growth media
41 Running and walking gait analysis, namely, optical measurements of gait cycle, gait asymmetries, gait rhythm for identification of gait abnormalities for the purpose of improving fitness and athletic performance
42 medical research services; providing online, non-downloadable software for medical practice management and for the management of patient medical records; medical care quality assessments, in particular quality management services, namely, quality evaluation and analysis in the field of orthopaedics; cell harvesting for medical purposes, namely, stem cell research services
44 medical clinics; physician services; nursing services; conducting medical evaluations for patient triage; medical screening; medical diagnostic testing services, except for the analysis and testing of blood and other bodily fluids; medical testing services for diagnostic or treatment purposes, except for the screening, analysis and testing of blood and other bodily fluids; medical imaging; medical rehabilitation services in the nature of gait analysis; gait analysis, namely, optical measurements of gait cycle, gait asymmetries, gait rhythm for identification of gait abnormalities for the treatment of orthopaedic disease; orthopedic surgery services; physiotherapy services; pedorthotics services; patient education services, namely, providing medical information in the form of reports to patients in the field of orthopedic care and in the field of administering medications; medical services, namely, measurement of growth factor deficiencies in patients and application of growth factors for the purposes of skin and bone healing, tissue repair and reducing inflammation and scarring by a doctor; medical services, namely, stem cell therapy; cell harvesting for medical purposes, namely, stem cell therapy services
Aug 17, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 17, 2021
Published For Opposition
Jul 28, 2021
Notification Of Notice Of Publication E-Mailed
Jul 13, 2021
Law Office Publication Review Completed
Jul 8, 2021
Approved For Pub - Principal Register
Jul 8, 2021
Examiner's Amendment Entered
Jul 7, 2021
Notification Of Examiners Amendment E-Mailed
Jul 7, 2021
Examiners Amendment E-Mailed
Jul 7, 2021
Examiners Amendment -Written
Jul 1, 2021
Previous Allowance Count Withdrawn
Jun 15, 2021
Withdrawn From Pub - Og Review Query
May 28, 2021
Approved For Pub - Principal Register
May 28, 2021
Examiner's Amendment Entered
May 27, 2021
Notification Of Examiners Amendment E-Mailed
May 27, 2021
Examiners Amendment E-Mailed
May 27, 2021
Examiners Amendment -Written
May 6, 2021
Teas/Email Correspondence Entered
May 6, 2021
Correspondence Received In Law Office
May 6, 2021
Teas Response To Office Action Received
Jan 7, 2021
Notification Of Non-Final Action E-Mailed
Jan 7, 2021
Non-Final Action E-Mailed
Jan 7, 2021
Non-Final Action Written
Nov 13, 2020
Notification Of Non-Final Action E-Mailed
Nov 13, 2020
Non-Final Action E-Mailed
Nov 13, 2020
Non-Final Action Written
Oct 13, 2020
Teas/Email Correspondence Entered
Oct 13, 2020
Correspondence Received In Law Office
Sep 28, 2020
Teas Response To Office Action Received
Apr 6, 2020
Notification Of Non-Final Action E-Mailed
Apr 6, 2020
Non-Final Action E-Mailed
Apr 6, 2020
Non-Final Action Written
Feb 6, 2020
Notification Of Final Refusal Emailed
Feb 6, 2020
Final Refusal E-Mailed
Feb 6, 2020
Final Refusal Written
Feb 4, 2020
Teas/Email Correspondence Entered
Feb 4, 2020
Correspondence Received In Law Office
Jan 31, 2020
Teas Response To Office Action Received
Dec 18, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 18, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 20, 2019
Notification Of Non-Final Action E-Mailed
Aug 20, 2019
Non-Final Action E-Mailed
Aug 20, 2019
Non-Final Action Written
Aug 2, 2019
Teas/Email Correspondence Entered
Aug 2, 2019
Correspondence Received In Law Office
Aug 2, 2019
Teas Response To Suspension Inquiry Received
Mar 20, 2019
Notification Of Inquiry As To Suspension E-Mailed
Mar 20, 2019
Inquiry To Suspension E-Mailed
Mar 20, 2019
Suspension Inquiry Written
Feb 22, 2019
Teas/Email Correspondence Entered
Feb 22, 2019
Correspondence Received In Law Office
Feb 15, 2019
Teas Response To Suspension Inquiry Received
Aug 21, 2018
Notification Of Inquiry As To Suspension E-Mailed
Aug 21, 2018
Inquiry To Suspension E-Mailed
Aug 21, 2018
Suspension Inquiry Written
Mar 29, 2018
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 29, 2018
Teas Change Of Owner Address Received
Feb 12, 2018
Notification Of Letter Of Suspension E-Mailed
Feb 12, 2018
Letter Of Suspension E-Mailed
Feb 12, 2018
Suspension Letter Written
Feb 12, 2018
Teas/Email Correspondence Entered
Feb 12, 2018
Correspondence Received In Law Office
Feb 9, 2018
Teas Response To Suspension Inquiry Received
Sep 6, 2017
Notification Of Inquiry As To Suspension E-Mailed
Sep 6, 2017
Inquiry To Suspension E-Mailed
Sep 6, 2017
Suspension Inquiry Written
Aug 23, 2017
Automatic Update Of Assignment Of Ownership
Aug 23, 2017
Teas/Email Correspondence Entered
Aug 23, 2017
Correspondence Received In Law Office
Aug 21, 2017
Teas Response To Suspension Inquiry Received
Aug 10, 2017
Notification Of Letter Of Suspension E-Mailed
Aug 10, 2017
Letter Of Suspension E-Mailed
Aug 10, 2017
Suspension Letter Written
Jul 17, 2017
Lie Checked Susp - To Atty For Action
Jul 17, 2017
Assigned To Lie
Dec 30, 2016
Notification Of Letter Of Suspension E-Mailed
Dec 30, 2016
Letter Of Suspension E-Mailed
Dec 30, 2016
Suspension Letter Written
Dec 10, 2016
Teas/Email Correspondence Entered
Dec 9, 2016
Correspondence Received In Law Office
Dec 9, 2016
Teas Response To Office Action Received
Jun 9, 2016
Notification Of Non-Final Action E-Mailed
Jun 9, 2016
Non-Final Action E-Mailed
Jun 9, 2016
Non-Final Action Written
Jun 8, 2016
Assigned To Examiner
Mar 1, 2016
Notice Of Pseudo Mark E-Mailed
Feb 29, 2016
New Application Office Supplied Data Entered In Tram
Feb 27, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
